|
|
OTC Healthcare in France to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 189 seiten | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in France. This report is a comprehensive resource for market, category and segment level data including valu.....
Introduction This databook provides key data and information on the OTC healthcare market in France. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in France increased at a compound annual growth rate of 2.3% between 2003 and 2008. The traditional medicines category led the OTC healthcare market in France, accounting for a share of 20.1%. Leading players in French OTC healthcare market include Procter & Gamble Company, The, Sanofi-Aventis and Reckitt Benckiser PLC. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in France *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 30 Value analysis (Euro), 2003?08 30 Value analysis (Euro), 2008?13 32 Value analysis (US dollars), 2003?08 34 Value analysis (US dollars), 2008?13 35 Company and brand share analysis 37 Distribution analysis 44 Chapter 4 Leading Company Profiles 46 The Procter & Gamble Company 46 Sanofi-Aventis SA 48 Chapter 5 Category Analysis: Analgesics 50 Value analysis (Euro), 2003?08 50 Value analysis (Euro), 2008?13 51 Value analysis (US dollars), 2003?08 53 Value analysis (US dollars), 2008?13 54 Company and brand share analysis 56 Distribution analysis 59 Chapter 6 Category Analysis: Topical OTC Medicines 61 Value analysis (Euro), 2003?08 61 Value analysis (Euro), 2008?13 62 Value analysis (US dollars), 2003?08 64 Value analysis (US dollars), 2008?13 65 Company and brand share analysis 67 Distribution analysis 70 Chapter 7 Category Analysis: Cough and Cold Preparations 72 Value analysis (Euro), 2003?08 72 Value analysis (Euro), 2008?13 73 Value analysis (US dollars), 2003?08 75 Value analysis (US dollars), 2008?13 76 Company and brand share analysis 78 Distribution analysis 81 Chapter 8 Category Analysis: Indigestion Preparations 83 Value analysis (Euro), 2003?08 83 Value analysis (Euro), 2008?13 84 Value analysis (US dollars), 2003?08 86 Value analysis (US dollars), 2008?13 86 Company and brand share analysis 88 Distribution analysis 91 Chapter 9 Category Analysis: Medicated Skin Products 93 Value analysis (Euro), 2003?08 93 Value analysis (Euro), 2008?13 94 Value analysis (US dollars), 2003?08 96 Value analysis (US dollars), 2008?13 97 Company and brand share analysis 99 Distribution analysis 102 Chapter 10 Category Analysis: First Aid Kits 104 Value analysis (Euro), 2003?08 104 Value analysis (Euro), 2008?13 105 Value analysis (US dollars), 2003?08 106 Value analysis (US dollars), 2008?13 106 Company and brand share analysis 107 Distribution analysis 110 Chapter 11 Category Analysis: Other OTC Healthcare Products 112 Value analysis (Euro), 2003?08 112 Value analysis (Euro), 2008?13 113 Value analysis (US dollars), 2003?08 115 Value analysis (US dollars), 2008?13 116 Company and brand share analysis 118 Distribution analysis 121 Chapter 12 Category Analysis: Plasters & Bandages 123 Value analysis (Euro), 2003?08 123 Value analysis (Euro), 2008?13 124 Value analysis (US dollars), 2003?08 126 Value analysis (US dollars), 2008?13 127 Company and brand share analysis 129 Distribution analysis 132 Chapter 13 Category Analysis: Traditional Medicines 134 Value analysis (Euro), 2003?08 134 Value analysis (Euro), 2008?13 135 Value analysis (US dollars), 2003?08 136 Value analysis (US dollars), 2008?13 136 Company and brand share analysis 137 Distribution analysis 139 Chapter 14 Category Analysis: Vitamins and Minerals 141 Value analysis (Euro), 2003?08 141 Value analysis (Euro), 2008?13 142 Value analysis (US dollars), 2003?08 144 Value analysis (US dollars), 2008?13 144 Company and brand share analysis 146 Distribution analysis 148 Chapter 15 Country Comparison 150 Value 150 Market share 154 Chapter 16 PESTLE Analysis 155 Summary 155 Political analysis 156 Economic analysis 159 Social analysis 163 Technology analysis 166 Legal analysis 169 Environmental analysis 172 Chapter 17 New Product Development 176 Product launches over time 176 Recent product launches 178 Chapter 18 Macroeconomic Profile 179 Macroeconomic indicators 179 Chapter 19 Research Methodology 184 Methodology overview 184 Secondary research 185 Market modeling 186 Creating an initial data model 186 Revising the initial data model 186 Creating a final estimate 187 Creating demographic value splits 187 Primary research 187 Data finalization 188 Ongoing research 188 Chapter 20 APPENDIX 189 Future readings 189 How to contact experts in your industry 189 Disclaimer 189 LIST OF FIGURES Figure 1: France OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 33 Figure 2: France OTC healthcare category growth comparison, by value, 2003?13 36 Figure 3: France OTC healthcare company share, by value, 2007?08 (%) 41 Figure 4: France OTC healthcare distribution channels, by value, 2007?08 (%) 45 Figure 5: France analgesics value and value forecast, 2003?13 (€m, nominal prices) 52 Figure 6: France analgesics category growth comparison, by value, 2003?13 55 Figure 7: France analgesics company share, by value, 2007?08 (%) 57 Figure 8: France analgesics distribution channels, by value, 2007?08 (%) 60 Figure 9: France topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 63 Figure 10: France topical OTC medicines category growth comparison, by value, 2003?13 66 Figure 11: France topical OTC medicines company share, by value, 2007?08 (%) 68 Figure 12: France topical OTC medicines distribution channels, by value, 2007?08 (%) 71 Figure 13: France cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 74 Figure 14: France cough and cold preparations category growth comparison, by value, 2003?13 77 Figure 15: France cough and cold preparations company share, by value, 2007?08 (%) 79 Figure 16: France cough and cold preparations distribution channels, by value, 2007?08 (%) 82 Figure 17: France indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 85 Figure 18: France indigestion preparations category growth comparison, by value, 2003?13 87 Figure 19: France indigestion preparations company share, by value, 2007?08 (%) 89 Figure 20: France indigestion preparations distribution channels, by value, 2007?08 (%) 92 Figure 21: France medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 95 Figure 22: France medicated skin products category growth comparison, by value, 2003?13 98 Figure 23: France medicated skin products company share, by value, 2007?08 (%) 100 Figure 24: France medicated skin products distribution channels, by value, 2007?08 (%) 103 Figure 25: France first aid kits value and value forecast, 2003?13 (€m, nominal prices) 105 Figure 26: France first aid kits company share, by value, 2007?08 (%) 108 Figure 27: France first aid kits distribution channels, by value, 2007?08 (%) 111 Figure 28: France other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 114 Figure 29: France other OTC healthcare products category growth comparison, by value, 2003?13 117 Figure 30: France other OTC healthcare products company share, by value, 2007?08 (%) 119 Figure 31: France other OTC healthcare products distribution channels, by value, 2007?08 (%) 122 Figure 32: France plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 125 Figure 33: France plasters & bandages category growth comparison, by value, 2003?13 128 Figure 34: France plasters & bandages company share, by value, 2007?08 (%) 130 Figure 35: France plasters & bandages distribution channels, by value, 2007?08 (%) 133 Figure 36: France traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 135 Figure 37: France traditional medicines distribution channels, by value, 2007?08 (%) 140 Figure 38: France vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 143 Figure 39: France vitamins and minerals category growth comparison, by value, 2003?13 145 Figure 40: France vitamins and minerals distribution channels, by value, 2007?08 (%) 149 Figure 41: Global OTC healthcare market split (value terms, 2008), top five countries 151 Figure 42: Global OTC healthcare market value, 2003–08, top five countries 153 Figure 43: Annual data review process 185 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: France OTC healthcare value, 2003?08 (€m, nominal prices) 31 Table 4: France OTC healthcare value forecast, 2008?13 (€m, nominal prices) 32 Table 5: France OTC healthcare value, 2003?08 ($m, nominal prices) 34 Table 6: France OTC healthcare value forecast, 2008?13 ($m, nominal prices) 35 Table 7: France OTC healthcare brand share, by value, 2007?08 (%) 37 Table 8: France OTC healthcare value, by brand 2007?08 (€m, nominal prices) 39 Table 9: France OTC healthcare company share by value, 2007?08 (%) 42 Table 10: France OTC healthcare value, by company, 2007?08 (€m, nominal prices) 43 Table 11: France OTC healthcare distribution channels, by value, 2007?08 (%) 44 Table 12: France OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 44 Table 13: The Procter & Gamble Company key facts 46 Table 14: Sanofi-Aventis SA key facts 48 Table 15: France analgesics value, 2003?08 (€m, nominal prices) 50 Table 16: France analgesics value forecast, 2008?13 (€m, nominal prices) 51 Table 17: France analgesics value, 2003?08 ($m, nominal prices) 53 Table 18: France analgesics value forecast, 2008?13 ($m, nominal prices) 54 Table 19: France analgesics brand share, by value, 2007?08 (%) 56 Table 20: France analgesics value, by brand 2007?08 (€m, nominal prices) 56 Table 21: France analgesics company share by value, 2007?08 (%) 58 Table 22: France analgesics value, by company, 2007?08 (€m, nominal prices) 58 Table 23: France analgesics distribution channels, by value, 2007?08 (%) 59 Table 24: France analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 59 Table 25: France topical OTC medicines value, 2003?08 (€m, nominal prices) 61 Table 26: France topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 62 Table 27: France topical OTC medicines value, 2003?08 ($m, nominal prices) 64 Table 28: France topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 65 Table 29: France topical OTC medicines brand share, by value, 2007?08 (%) 67 Table 30: France topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 67 Table 31: France topical OTC medicines company share by value, 2007?08 (%) 69 Table 32: France topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 69 Table 33: France topical OTC medicines distribution channels, by value, 2007?08 (%) 70 Table 34: France topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 70 Table 35: France cough and cold preparations value, 2003?08 (€m, nominal prices) 72 Table 36: France cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 73 Table 37: France cough and cold preparations value, 2003?08 ($m, nominal prices) 75 Table 38: France cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 76 Table 39: France cough and cold preparations brand share, by value, 2007?08 (%) 78 Table 40: France cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 78 Table 41: France cough and cold preparations company share by value, 2007?08 (%) 80 Table 42: France cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 80 Table 43: France cough and cold preparations distribution channels, by value, 2007?08 (%) 81 Table 44: France cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 81 Table 45: France indigestion preparations value, 2003?08 (€m, nominal prices) 83 Table 46: France indigestion preparations value forecast, 2008?13 (€m, nominal prices) 84 Table 47: France indigestion preparations value, 2003?08 ($m, nominal prices) 86 Table 48: France indigestion preparations value forecast, 2008?13 ($m, nominal prices) 86 Table 49: France indigestion preparations brand share, by value, 2007?08 (%) 88 Table 50: France indigestion preparations value, by brand 2007?08 (€m, nominal prices) 88 Table 51: France indigestion preparations company share by value, 2007?08 (%) 90 Table 52: France indigestion preparations value, by company, 2007?08 (€m, nominal prices) 90 Table 53: France indigestion preparations distribution channels, by value, 2007?08 (%) 91 Table 54: France indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 91 Table 55: France medicated skin products value, 2003?08 (€m, nominal prices) 93 Table 56: France medicated skin products value forecast, 2008?13 (€m, nominal prices) 94 Table 57: France medicated skin products value, 2003?08 ($m, nominal prices) 96 Table 58: France medicated skin products value forecast, 2008?13 ($m, nominal prices) 97 Table 59: France medicated skin products brand share, by value, 2007?08 (%) 99 Table 60: France medicated skin products value, by brand 2007?08 (€m, nominal prices) 99 Table 61: France medicated skin products company share by value, 2007?08 (%) 101 Table 62: France medicated skin products value, by company, 2007?08 (€m, nominal prices) 101 Table 63: France medicated skin products distribution channels, by value, 2007?08 (%) 102 Table 64: France medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 102 Table 65: France first aid kits value, 2003?08 (€m, nominal prices) 104 Table 66: France first aid kits value forecast, 2008?13 (€m, nominal prices) 105 Table 67: France first aid kits value, 2003?08 ($m, nominal prices) 106 Table 68: France first aid kits value forecast, 2008?13 ($m, nominal prices) 106 Table 69: France first aid kits brand share, by value, 2007?08 (%) 107 Table 70: France first aid kits value, by brand 2007?08 (€m, nominal prices) 107 Table 71: France first aid kits company share by value, 2007?08 (%) 109 Table 72: France first aid kits value, by company, 2007?08 (€m, nominal prices) 109 Table 73: France first aid kits distribution channels, by value, 2007?08 (%) 110 Table 74: France first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 110 Table 75: France other OTC healthcare products value, 2003?08 (€m, nominal prices) 112 Table 76: France other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 113 Table 77: France other OTC healthcare products value, 2003?08 ($m, nominal prices) 115 Table 78: France other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 116 Table 79: France other OTC healthcare products brand share, by value, 2007?08 (%) 118 Table 80: France other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 118 Table 81: France other OTC healthcare products company share by value, 2007?08 (%) 120 Table 82: France other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 120 Table 83: France other OTC healthcare products distribution channels, by value, 2007?08 (%) 121 Table 84: France other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 121 Table 85: France plasters & bandages value, 2003?08 (€m, nominal prices) 123 Table 86: France plasters & bandages value forecast, 2008?13 (€m, nominal prices) 124 Table 87: France plasters & bandages value, 2003?08 ($m, nominal prices) 126 Table 88: France plasters & bandages value forecast, 2008?13 ($m, nominal prices) 127 Table 89: France plasters & bandages brand share, by value, 2007?08 (%) 129 Table 90: France plasters & bandages value, by brand 2007?08 (€m, nominal prices) 129 Table 91: France plasters & bandages company share by value, 2007?08 (%) 131 Table 92: France plasters & bandages value, by company, 2007?08 (€m, nominal prices) 131 Table 93: France plasters & bandages distribution channels, by value, 2007?08 (%) 132 Table 94: France plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 132 Table 95: France traditional medicines value, 2003?08 (€m, nominal prices) 134 Table 96: France traditional medicines value forecast, 2008?13 (€m, nominal prices) 135 Table 97: France traditional medicines value, 2003?08 ($m, nominal prices) 136 Table 98: France traditional medicines value forecast, 2008?13 ($m, nominal prices) 136 Table 99: France traditional medicines brand share, by value, 2007?08 (%) 137 Table 100: France traditional medicines value, by brand 2007?08 (€m, nominal prices) 137 Table 101: France traditional medicines company share by value, 2007?08 (%) 138 Table 102: France traditional medicines value, by company, 2007?08 (€m, nominal prices) 138 Table 103: France traditional medicines distribution channels, by value, 2007?08 (%) 139 Table 104: France traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 139 Table 105: France vitamins and minerals value, 2003?08 (€m, nominal prices) 141 Table 106: France vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 142 Table 107: France vitamins and minerals value, 2003?08 ($m, nominal prices) 144 Table 108: France vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 144 Table 109: France vitamins and minerals brand share, by value, 2007?08 (%) 146 Table 110: France vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 146 Table 111: France vitamins and minerals company share by value, 2007?08 (%) 147 Table 112: France vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 147 Table 113: France vitamins and minerals distribution channels, by value, 2007?08 (%) 148 Table 114: France vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 148 Table 115: Global OTC healthcare market value, 2008 150 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 153 Table 117: Leading players, top five countries 154 Table 118: Analysis of France’s political landscape 156 Table 119: Analysis of France’s economy 159 Table 120: Analysis of France’s social system 163 Table 121: Analysis of France’s technology landscape 166 Table 122: Analysis of France’s legal landscape 169 Table 123: Analysis of France’s environmental landscape 172 Table 124: France OTC healthcare new product launches reports, by company (top five companies), 2008 176 Table 125: France OTC healthcare new product launches SKUs, by company (top five companies), 2008 176 Table 126: France OTC healthcare new product launches (reports), by flavor and fragrances (top 10 flavors), 2008 177 Table 127: France OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 177 Table 128: France OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2008 178 Table 129: France OTC healthcare new product launches - recent five launches 2008 178 Table 130: France population, by age group, 2003?08 (millions) 179 Table 131: France population forecast, by age group, 2008?13 (millions) 180 Table 132: France population, by gender, 2003?08 (millions) 180 Table 133: France population forecast, by gender, 2008?13 (millions) 181 Table 134: France nominal GDP, 2003?08 (€bn, nominal prices) 181 Table 135: France nominal GDP forecast, 2008?13 (€bn, nominal prices) 181 Table 136: France real GDP, 2003?08 (€bn, 2000 prices) 182 Table 137: France real GDP forecast, 2008?13 (€bn, 2000 prices) 182 Table 138: France real GDP, 2003?08 ($bn, 2000 prices) 182 Table 139: France real GDP forecast, 2008?13 ($bn, 2000 prices) 183 Table 140: France consumer price index, 2003?08 (2000=100) 183 Table 141: France consumer price index, 2008?13 (2000=100) 183 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


